Srinivas Akkaraju - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made 1 insider transaction in Syros Pharmaceuticals Inc (SYRS) with a net purchase of 904,977. Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 42,622 shares made by David Roth , a net sale of 171,783 shares made by Nancy A Simonian , and a net sale of 37,803 shares made by Jason Haas .

In summary, during the past 3 months, insiders sold 539,272 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 539,272 shares. During the past 18 months, 570,484 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 534,493 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 19,816 shares made by Vaughn B Himes , a net sale of 1,746 shares made by Charles R Romp , and a net sale of 5,116 shares made by Roger D Dansey .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,272 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,272 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of ZS Pharma Inc (ZSPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ZS Pharma Inc (ZSPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ZS Pharma Inc (ZSPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 12,000 shares made by Joseph Monahan , and a net purchase of 666,666 shares made by Anand Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 666,666 shares, with a net purchase of 666,666 shares. During the past 18 months, 12,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 5,544,913 shares were bought by its insiders, resulting in a net purchase of 5,532,913 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Spark Therapeutics Inc (ONCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spark Therapeutics Inc (ONCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spark Therapeutics Inc (ONCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net purchase of 25,000 shares made by Kirsten Castillo , and a net purchase of 10,000 shares made by Prabhavathi Fernandes .

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 35,000 shares, with a net purchase of 35,000 shares. During the past 18 months, 0 shares of Ocugen Inc (OCGN) were sold and 35,000 shares were bought by its insiders, resulting in a net purchase of 35,000 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 579,000 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in MEI Pharma Inc (MEIP). Other recent insider transactions involving MEI Pharma Inc (MEIP) include a net purchase of 201,660 shares made by Anson Funds Management Lp , and a net purchase of 134,440 shares made by Funicular Funds, Lp .

In summary, during the past 3 months, insiders sold 0 shares of MEI Pharma Inc (MEIP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MEI Pharma Inc (MEIP) were sold and 336,100 shares were bought by its insiders, resulting in a net purchase of 336,100 shares.

MEI Pharma Inc (MEIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Chinook Therapeutics Inc (KDNY). Other recent insider transactions involving Chinook Therapeutics Inc (KDNY) include a net sale of 1,168 shares made by Andrew James King ,

In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,168 shares.

Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Graphite Bio Inc (GRPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graphite Bio Inc (GRPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Graphite Bio Inc (GRPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Jiya Acquisition Corp (JYAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiya Acquisition Corp (JYAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jiya Acquisition Corp (JYAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made 2 insider transaction in Scholar Rock Holding Corp (SRRK) with a net purchase of 1,014,068. Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 336,643 shares made by Edward H Myles , a net sale of 35,372 shares made by Mo Qatanani , and a net sale of 13,709 shares made by Caryn Parlavecchio .

In summary, during the past 3 months, insiders sold 3,578,573 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 3,578,573 shares. During the past 18 months, 3,729,751 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,579,493 shares were bought by its insiders, resulting in a net purchase of 2,849,742 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Srinivas Akkaraju made no insider transaction in Mineralys Therapeutics Inc (MLYS). Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 142,377 shares made by Jon Congleton , a net sale of 262,849 shares made by David Malcom Rodman , and a net sale of 118,329 shares made by Adam Scott Levy .

In summary, during the past 3 months, insiders sold 56,536 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 56,536 shares. During the past 18 months, 1,084,305 shares of Mineralys Therapeutics Inc (MLYS) were sold and 566,305 shares were bought by its insiders, resulting in a net sale of 518,000 shares.

Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.